Cargando…
Hmga2 functions as a competing endogenous RNA to promote lung cancer progression
Non-small cell lung cancer (NSCLC) is the most prevalent histological cancer subtype worldwide(1). As the majority of patients present with invasive, metastatic disease(2), it is vital to understand the basis for lung cancer progression. Hmga2 is highly expressed in metastatic lung adenocarcinoma wh...
Autores principales: | Kumar, Madhu S., Armenteros-Monterroso, Elena, East, Philip, Chakravorty, Probir, Matthews, Nik, Winslow, Monte M., Downward, Julian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886898/ https://www.ncbi.nlm.nih.gov/pubmed/24305048 http://dx.doi.org/10.1038/nature12785 |
Ejemplares similares
-
LINC00152 acts as a competing endogenous RNA of HMGA1 to promote the growth of gastric cancer cells
por: Chen, Jiayi, et al.
Publicado: (2022) -
Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance
por: Chiou, Shin-Heng, et al.
Publicado: (2018) -
Let-7 Represses Carcinogenesis and a Stem Cell Phenotype in the Intestine via Regulation of Hmga2
por: Madison, Blair B., et al.
Publicado: (2015) -
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs
por: Esposito, Francesco, et al.
Publicado: (2014) -
Competing endogenous RNA network for esophageal cancer progression
por: Chen, Saihua, et al.
Publicado: (2021)